ATIKU PLEDGES SCHOLARSHIP TO VIRAL NIGER TEEN MINER. (PHOTO).

Image
 Atiku pledges scholarship to viral Niger teen miner Former Vice President Atiku Abubakar on Sunday said his “heart breaks” each time he watches a viral video of a teenage artisanal miner, Yusuf Aliyu, speaking at a mining site in Niger State after the deaths of 37 miners in the state. Atiku, in a statement posted on his X handle, said he was prepared to support the boy’s education, describing him as a child whose intelligence and confidence should be nurtured in a classroom rather than by working at a mining site. “I have watched Yusuf Aliyu’s video repeatedly, and each time, my heart breaks. A child with such intelligence, clarity and confidence should be in a classroom building his future—not struggling for survival in a community surrounded by gold but buried in poverty. “I cannot look at him and see an ‘illegal miner.’ I see a Nigerian child failed by the country that should have protected him. I see brilliance trapped by poverty and enormous promise abandoned by leadership,” ...

GSK SEEKS APPROVAL FOR WORLD'S FIRST MALARIA VACCINE.

A jogger runs past a signage for pharmaceutical giant GlaxoSmithKline (GSK) in London April 22, 2014. REUTERS/Luke MacGregor            According to sources,the company Glaxo Smith Kline {GSK} said today thursday that it is applying for regulatory approval for the world's first vaccine against malaria,designed for children in Africa.The British drugmaker said the shot called RTS,S,is intended exclusively for use outside the European union but will be evaluated by the European medicines Agency {EMA} in collaboration with World Health Organisation {WHO}.Malaria,a mosquito borne parastic disease,kills more than 600,000 people a year,mainly babies in the poorest parts of sub Saharan Africa.Experts have long hoped that scientists would be able to develop an effective vaccine against the disease,and scientists at GSK have been working on this one for 30 years.The WHO,has previously indicated it may recommend use of RTS,S from as early as 2015 if EMA drugs regulators back its license application.GSK has been developing RTS,S with the non profit PATH malaria vaccine initiative {MVI},with grant funding from the Bill and Melinda Gates foundation to MVI.The vaccine also contains an adjuvant,or booster,made by U.S biotech company Agenus,which received an undisclosed milestone payment for the regulatory submission.

Comments

Popular posts from this blog

MUSICIAN HARRY-SONG,REVEALS THE FACE OF THE FEMALE FAN WHO IS THREATENING TO KILL HIM.{PHOTOS}.

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

THE NEW OONI OF ILE-IFE,WILL NOT EAT THE HEART OF THE LATE OONI-PALACE CHIEFS.